Serum vascular endothelial growth factor as a possible indicator of arterial reactivity in postmenopausal women

References

• Rossouw J E, Anderson G L, Prentice R L, LaCroix A Z, Kooperberg C, Stefanick M L, Jackson R D, Beresford S A, Howard B V, Johnson K C, et al. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002; 288: 321–233
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, et al. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). J Am Med Assoc 2002; 288: 49–57
   PubMed Web of Science ®Google Scholar
• Mendelsohn M, Karas R. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801–1811
   PubMed Web of Science ®Google Scholar
• Maas A, Van Der Schouw Y, Grobbee D, Van Der Graaf Y. ‘Rise and fall’ of hormone therapy in postmenopausal women with cardiovascular disease. Menopause 2004; 11: 228–235
   Google Scholar
• Mikkola T, Clarkson T. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002; 53: 605–619
   PubMed Web of Science ®Google Scholar
• Mori T, Durand J, Chen Y, Thompson J, Bakir S, Oparil S. Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery. Am J Cardiol 2000; 85: 1276–1279
   Google Scholar
• Herrington D, Espeland M, Crouse J R, 3rd, Robertson J, Riley W, McBurnie M, Burke G L. Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler Thromb Vasc Biol 2001; 21: 1955–1961
   PubMed Web of Science ®Google Scholar
• Celermajer D, Sorensen K, Gooch V, Spiegelhalter D, Miller O, Sullivan I, Lloyd J K, Deanfield J E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Kozaki K, Eto M, Akishita M, Ako J, Iijima K, Kim S, Toba K, Yoshizumi M, Ouchi Y. Association of coronary risk factors and endothelium-dependent flow-mediated dilatation of the brachial artery. Hypertens Res 2000; 23: 233–238
   Google Scholar
• Blann A, Belgore F, McCollum C, Silverman S, Lip P, Lip G. Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or type II diabetes. Clin Sci (Lond) 2002; 102: 187–194
   PubMed Web of Science ®Google Scholar
• Yin R, Feng J, Chen D, Wu H. Serum levels of vascular endothelial growth factor in patients with angina pectoris and acute myocardial infarction. Chin Med Sci J 2000; 15: 205–209
   Google Scholar
• Leung D W, Cachianes G, Kuang W J, Goeddel D V, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–1309
   PubMed Web of Science ®Google Scholar
• Nicosia R F, Nicosia S V, Smith M. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 1994; 145: 1023–1029
   PubMed Web of Science ®Google Scholar
• Lam P, Yim S, Briton-Jones C, Chung T, Haines C. Raloxifene therapy in postmenopausal women is associated with a significant reduction in the concentration of serum vascular endothelial growth factor. Fertil Steril 2004; 81: 393–397
   Google Scholar
• Yim S, Lau T, Sahota D, Chung T, Chang A, Haines C. Prospective randomized study of the effect of ‘add-back’ hormone replacement on vascular function during treatment with gonadotropin-releasing hormone agonists. Circulation 1998; 98: 1631–1635
   Google Scholar
• Lau T, Chung T, Haines C. A preliminary study on the effect of hormone replacement therapy on peripheral flow velocity in postmenopausal women. Maturitas 1997; 26: 53–56
   PubMedGoogle Scholar
• Corretti M, Anderson T, Benjamin E, Celermajer D, Charbonneau F, Creager M, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257–265
   PubMed Web of Science ®Google Scholar
• Conway D, Pearce L, Chin B, Hart R, Lip G. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation 2002; 106: 1962–1967
   PubMed Web of Science ®Google Scholar
• Joannides R, Haefeli W, Linder L, Richard V, Bakkali E, Thuillez C, Luscher T F. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314–1319
   PubMed Web of Science ®Google Scholar
• van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner J M. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997; 95: 1030–1037
   PubMed Web of Science ®Google Scholar
• Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner J M. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997; 3: 879–886
   PubMed Web of Science ®Google Scholar
• Colacurci N, Manzella D, Fornaro F, Carbonella M, Paolisso G. Endothelial function and menopause: effects of raloxifene administration. J Clin Endocrinol Metab 2003; 88: 2135–2140
   PubMed Web of Science ®Google Scholar
• Balligand J. New mechanisms of LDL-cholesterol induced endothelial dysfunction; correction by statins. Bull Mem Acad R Med Belg 2002; 157: 427–434
   Google Scholar